Hybrid treatment of recurrent atrial fibrillation associated with COVID-19

Zhigalkovich A.S.; Chasnoits A.R.; Zhmailik R.R.

doi:https://doi.org/10.17116/Cardiobulletin20211604176

Zhigalkovich A.S.

Republican Scientific and Practical Centre «Cardiology»

Chasnoits A.R.

Republican Scientific and Practical Centre «Cardiology»

Zhmailik R.R.

Republican Scientific and Practical Centre «Cardiology»

Hybrid treatment of recurrent atrial fibrillation associated with COVID-19

Authors:

Zhigalkovich A.S., Chasnoits A.R., Zhmailik R.R.

More about the authors

Journal: Russian Cardiology Bulletin. 2021;16(4): 76‑80

DOI: 10.17116/Cardiobulletin20211604176

Read: 2280 times

Download PDF (RU)

Contact the author

Table of contents

To cite this article:

Zhigalkovich AS, Chasnoits AR, Zhmailik RR. Hybrid treatment of recurrent atrial fibrillation associated with COVID-19. Russian Cardiology Bulletin. 2021;16(4):76‑80. (In Russ.)
https://doi.org/10.17116/Cardiobulletin20211604176

Подписка 2026 Кардиологический вестник (Russian Cardiology Bulletin)

Использование инфографики авторами научных работ

Close metadata

OBJECTIVE

To present the results of hybrid surgical treatment of recurrent atrial fibrillation (AF) in a patient with previous COVID-19 infection.

MATERIAL AND METHODS

The patient admitted to the 1^st cardiac surgery department of the Republican Scientific and Practical Centre «Cardiology» with persistently recurrent form of atrial fibrillation. Considering clinical course of arrhythmia, tachycardia-induced cardiomyopathy, low efficiency of electrical cardioversion and antiarrhythmic therapy, we performed hybrid ablation. At the first stage, epicardial video-assisted radiofrequency ablation of the left and right atria was carried out. The next stage included transcatheter endocardial cryoablation of pulmonary veins and cavo-tricuspid isthmus within the same admission.

RESULTS AND DISCUSSION

Epicardial ablation made it possible to eliminate AF in this patient. However, this procedure possibly predisposed to atypical atrial flutter. Endocardial ablation ensured complete isolation of pulmonary veins and restoration of stable sinus rhythm.

CONCLUSION

Hybrid ablation in a patient with COVID-associated atrial fibrillation was valuable for rhythm control strategy despite persistent arrhythmia and previous ineffective cardioversion.

Keywords:

atrial fibrillation

COVID-19

radiofrequency ablation

Authors:

Zhigalkovich A.S.

Republican Scientific and Practical Centre «Cardiology»

Chasnoits A.R.

Republican Scientific and Practical Centre «Cardiology»

Zhmailik R.R.

Republican Scientific and Practical Centre «Cardiology»

Received:

13.10.2021

Accepted:

15.11.2021

Close metadata

References:

World Health Organization. Novel Coronavirus (2019-nCoV). Situation Report — 11 [Electronic resource]. Accessed October 25, 2021. https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200131-sitrep-11-ncov.pdf?sfvrsn=de7c0f7_4
Driggin E, Madhavan MV, Bikdeli B, Chuich T, Laracy J, Biondi-Zoccai G, Brown TS, Der Nigoghossian C, Zidar DA, Haythe J, Brodie D, Beckman JA, Kirtane AJ, Stone GW, Krumholz HM, Parikh SA. Cardiovascular considerations for patients, health care workers, and health systems during the COVID-19 pandemic. Journal of the American College of Cardiology. 2020;75(18):2352-2371. https://doi.org/10.1016/j.jacc.2020.03.031
Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, Wang B, Xiang H, Cheng Z, Xiong Y, Zhao Y, Li Y, Wang X, Peng Z. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus — infected pneumonia in Wuhan, China. JAMA. 2020;323(11):1061-1069. https://doi.org/10.1001/jama.2020.1585
Inciardi RM, Adamo M, Lupi L, Cani DS, Di Pasquale M, Tomasoni D, Italia L, Zaccone G, Tedino C, Fabbricatore D, Curnis A, Faggiano P, Gorga E, Lombardi CM, Milesi G, Vizzardi E, Volpini M, Nodari S, Specchia C, Maroldi R, Bezzi M, Metra M. Characteristics and outcomes of patients hospitalized for COVID-19 and cardiac disease in Northern Italy. European Heart Journal. 2020;41(19):1821-1829. https://doi.org/10.1093/eurheartj/ehaa388
Harrison SL, Fazio-Eynullayeva E, Lane DA, Underhill P, Lip GYH. Atrial fibrillation and the risk of 30-day incident thromboembolic events, and mortality in adults ≥50 years with COVID-19. Journal of Arrhythmia. 2021;37(1):231-237. https://doi.org/10.1002/joa3.12458
Zhigalkovich AS. Hybrid atrial fibrillation surgery: a view of a cardiac surgeon. Kardiologiya v Belarusi. 2016;2(8):230-236. (In Russ.).
The European Society for Cardiology. ESC Guidance for the Diagnosis and Management of CV Disease during the COVID-19 Pandemic (Last update: 10 June 2020). [Electronic resource]. Accessed October 25, 2021. https://www.escardio.org/Education/COVID-19-and Cardiology/ESCCOVID-19-Guidance
Kottkamp H, Hindricks G. Beyond pulmonary vein isolation: the issue of reconduction. Journal of Cardiovascular Electrophysiology. 2009;20(12):1388-1390. https://doi.org/10.1111/j.1540-8167.2009.01581.x
Sy RW, Gula LJ, Leong-Sit P, Klein GJ, Yee R, Krahn AD, Bentley C, Razak S, Skanes AC. Complete antral encirclement is not required for pulmonary vein isolation. Heart Rhythm. 2011;8(1):16-22. https://doi.org/10.1016/j.hrthm.2010.09.069
Zhigalkovich AS. Minimally invasive surgery for atrial fibrillation. Kardiologiya v Belarusi. 2012;3(22):116-126. (In Russ.).
Lee AM, Aziz A, Clark KL, Schuessler RB, Damiano RJ Jr. Chronic performance of a novel radiofrequency ablation device on the beating heart: limitations of conduction delay to assess transmurality. The Journal of Thoracic and Cardiovascular Surgery. 2012;144(4):859-865. https://doi.org/10.1016/j.jtcvs.2012.01.001
Zhigalkovich AS. The results of minimally invasive bipolar epicardial radiofrequency ablation in patients with persistent form of isolated atrial fibrillation. Kardiologiya v Belarusi. 2015;41(4):26-33. (In Russ.).